Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview

BMC Health Services Research
Franklin Acheampong, Berko Panyin Anto

Abstract

Pharmacist involvement in the prevention of medication errors is well documented. One such method, the process by which hospital pharmacists undertake these clinical interventions needs to be described and documented. The perceived barriers to pharmacists succeeding in getting their recommendations accepted could inform future safety strategy development. This study was therefore to trace the typical process involved and explore the perceived barriers to pharmacists' medication safety efforts. This study involved a retrospective evaluation of routine clinical interventions collected at a tertiary hospital in Ghana over 23 months. A sample of pharmacists who had submitted these reports were then interviewed. The interventions made related to drug therapy changes (76.0%), monitoring (13.0%), communication (5.4%), counselling (5.0%) and adverse drug events (0.6%). More than 90% of interventions were accepted. The results also showed that undertaking clinical interventions by pharmacists followed a sequential order with two interlinked subprocesses: Problem Identification and Problem Handling. In identifying the problem, as much information needed to be gathered, clinical issues identified and then the problems prioritised. During ...Continue Reading

References

Oct 1, 1992·Medical Care·M T RuppS W Schondelmeyer
Jul 5, 1995·JAMA : the Journal of the American Medical Association·L L LeapeG Laffel
Oct 9, 1993·BMJ : British Medical Journal·R Robinson
Jul 28, 1997·Archives of Internal Medicine·T S LesarH Pohl
Jul 28, 1999·JAMA : the Journal of the American Medical Association·L L LeapeD W Bates
Dec 7, 2002·Quality & Safety in Health Care·B DeanN Barber
Mar 11, 2003·Critical Care Medicine·Eric J ThomasRobert L Helmreich
Jun 11, 2003·Surgery·Atul A GawandeTroyen A Brennan
Oct 4, 2003·Pharmacotherapy·Raymond W HammondUNKNOWN American College of Clinical Pharmacy
Oct 9, 2003·Quality & Safety in Health Care·K Taxis, N Barber
Nov 4, 2004·British Journal of Clinical Pharmacology·Henk BuurmaAntoine C G Egberts
Dec 22, 2004·International Journal of Nursing Practice·Marja Silén-LipponenAnn Smith
Aug 13, 2005·Pharmacy World & Science : PWS·Adnan BesoNick Barber
Aug 13, 2005·Pharmacy World & Science : PWS·Azuka C Oparah, Adego E Eferakeya
Jun 3, 2006·Journal of the American Pharmacists Association : JAPhA·David H KrelingJon C Schommer
May 28, 2008·Pharmacotherapy·UNKNOWN American College of Clinical Pharmacy
Aug 6, 2008·Quality & Safety in Health Care·G M KuoJ M Hickner
May 8, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Penny J LewisDarren M Ashcroft
Jan 20, 2010·Pharmacy World & Science : PWS·Claudia Langebrake, Heike Hilgarth
May 13, 2010·The Annals of Pharmacotherapy·Brian C LundPeter J Kaboli
Jul 16, 2011·Postgraduate Medical Journal·Bryony Dean FranklinAnn Jacklin
Aug 16, 2011·BMC Research Notes·Majed I Al-JeraisyMostafa A Abolfotouh
Jan 3, 2012·International Journal of Clinical Pharmacy·Ulrika GillespieMariann Hedström
Mar 2, 2012·Health Services Research·Rebecca LawtonRosie R C McEachan
Mar 6, 2012·The American Journal of Geriatric Pharmacotherapy·Timothy ReillyStanley Reuben
Mar 22, 2014·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Hussain Abdullah Mubarak Al RahbiHavagiray R Chitme

❮ Previous
Next ❯

Citations

Jun 10, 2017·International Journal of Clinical Pharmacy·Gordana LjubojevićSandra Vezmar Kovačević
Oct 23, 2018·PloS One·Genival Araujo Dos Santos JúniorDivaldo Pereira de Lyra
Aug 14, 2020·Journal of Evaluation in Clinical Practice·Genival Araujo Dos Santos JúniorDivaldo Pereira de Lyra-Jr
Jan 12, 2021·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Reham Faraj Al-AhmadiSheraz Ali

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.